ECMO UPDATES

Having worked extensively in critical care settings, I find staying current with ECMO protocols crucial to improving patient outcomes. Recent shifts towards direct thrombin inhibitors (DTIs) like bivalirudin replacing heparin, especially in centers following ELSO 2025-2026 guidance, are significant. In my experience, using anti-Xa assays instead of aPTT for heparin monitoring reduces clotting complications and the need for frequent circuit changes, which reduces risks and conserves resources. Hemodynamic targets such as maintaining mean arterial pressure (MAP) between 60-65 mmHg and arterial oxygen partial pressure (PaO2) within 60-150 mmHg have proven essential for optimizing perfusion without increasing risk. Avoiding rapid correction of arterial CO2 to prevent cerebral vasoconstriction aligns with best practices I've seen in neurocritical care. Volume management, particularly avoiding fluid overload and utilizing continuous renal replacement therapy (CRRT) to maintain dry weight, has been a lifesaver in many ECMO patients. Early and active left ventricular unloading in VA-ECMO cases, often through devices or pharmacologic means, is something I advocate strongly since studies link it to improved survival rates. Another vital consideration is understanding how ECMO circuits affect drug pharmacokinetics. I’ve noticed that lipophilic and protein-bound drugs like propofol, fentanyl, dexmedetomidine, and amiodarone may require dosage adjustments due to sequestration and altered clearance. This warrants close monitoring and regular therapeutic drug assessments. Lastly, it’s insightful that classic biomarkers for acute kidney injury like serum creatinine may not reliably reflect kidney status in ECMO patients. Emerging biomarkers such as NGAL and cystatin C provide a clearer picture and help tailor renal support therapy more effectively. Integrating these updates into daily ICU practice has enhanced my confidence in managing complex ECMO cases. Keeping abreast of evolving guidelines ensures that the best possible care is delivered to critically ill patients relying on this life-saving technology.